SUMMARY: Between July 2012 and March 2013, a total of 133 clinical specimens from 47 patients suspected of having measles were collected for virological surveillance in Aichi Prefecture, Japan. Facing the rubella epidemic, the reverse transcription (RT)-PCR protocol for measles virus (MeV) was modified to simultaneously detect rubella virus (RUBV) in these clinical specimens. As a result, 30 specimens from 15 patients were positive for RUBV and 8 specimens from 3 patients were positive for MeV. The RUBV genotype analysis for the samples from 13 patients revealed 12 samples as 2B and 1 sample as 1E. The results provided additional evidence for the difficulty in the diagnosis of exanthematous diseases based on clinical manifestations alone and the necessity of virological diagnosis to maintain the accuracy of case-based surveillance. Furthermore, the results indicated that the modified RT-PCR protocol could be useful as a routine procedure to simultaneously detect MeV and RUBV in clinical specimens of patients suspected of having exanthematous disease caused by these viruses.
Rubella, caused by rubella virus (RUBV), is usually a self-limiting disease, but maternal infection in early pregnancy often leads to birth defects known as congenital rubella syndrome (CRS). Thus, the World Health Organization (WHO) targets elimination of rubella, a vaccine-preventable disease (VPD) as well as measles, another VPD, caused by measles virus (MeV) (1) .
According to the National Epidemiological Surveillance of Infectious Diseases in Japan, rubella cases started to increase initially in the Kansai (mid-western) area in the late 2011 and the epidemic spread to other densely populated areas, including Aichi Prefecture by August 2012, and was endemic as of May 2013 (2, 3) . Because both rubella and measles are associated with rash, fever, and catarrhal symptoms, differential diagnosis based solely on clinical manifestations is occasionally unreliable, and laboratory tests, i.e., serology (detection of IgM and/or a significant increase in IgG titer) and/or virus detection/isolation, are helpful for the diagnosis (4, 5) . Because measles also resemble other infectious diseases caused by viruses, such as rubella, dengue, ECHO, coxsackie, human parvovirus B19 (B19V), and human herpesvirus 6, laboratory test-based diagnosis for such infections is necessary (4) . Facing the rubella epidemic for the first time since 2004, we employed the simultaneous detection method of RUBV and MeV for quicker reporting of the PCR results for RUBV to the administrative office and attending physicians who requested for virological diagnosis. We investigated the presence of RUBV and MeV (and in some cases, several other viruses) in clinical specimens collected from patients with exanthematous diseases.
From July 2012 to March 2013, 133 clinical specimens (43 throat swabs, 37 urine, 25 peripheral blood mononuclear cell, 15 serum, and 13 whole blood samples) were collected from 47 patients clinically diagnosed with or suspected of having measles, based primarily on skin and mucosal manifestations such as measles-like rash (47 patients) and/or Koplik spots (10 patients). An ethical approval was not required by our institution for the investigation on national infectious disease surveillance.
The viral RNA was prepared from 200 ml of each of the above-mentioned clinical specimens using the High Pure Viral RNA Kit (Roche, Mannheim, Germany) according to the manufacturer's instructions. The complimentary DNA was synthesized using PrimeScript RT Reagent Kit (TaKaRa BIO Inc., Kyoto, Japan), and RT-PCR was performed to detect MeV (H and N genes) as described previously (6) . The methods to simultaneously detect RUBV and MeV were developed as follows. First, the following PCR conditions were employed: 30 cycles of 989 C for 10 s, 589 C for 30 s, 729 C for 1 min, and 729 C for 3 min. Second, the following (nested) PCR conditions were employed: 30 cycles of 989 C for 10 s, 609 C for 30 s, 729 C for 1 min, and 729 C for 3 min. The 2 primer pairs for the first PCR and nested PCR to detect the RUBV NS gene are listed in Table 1 . The PCR reactions were performed using PerfectShot EX Taq (TaKaRa) in a Veriti Thermal Cycler (Life Technologies Corp., Carlsbad, CA, USA). The detection limit of this nested RT-PCR was determined to be 10 RNA copies/reaction using synthetic RUBV RNA. The specimens of RUBV-and MeV-negative cases were subjected to B19V DNA detection using PCR as described previ- ously (7) (8) (9) , and the isolation and identification of human enteroviruses and adenoviruses were attempted using HeLa cells, human rhabdomyosarcoma (RD)-18S cells, or African green monkey kidney (Vero) cells, as described previously (10, 11) . For RUBV genotyping, the E1 coding region containing the WHO-recommended sequence window was divided into 2 regions, E1-A and E1-B, which were individually amplified. The PCR conditions were similar to those described for the NS region. Briefly, the first PCR conditions were as follows: 949 C for 3 min, followed by 30 cycles of 989 C for 20 s, 619 C for 30 s, 729 C for 1 min, and 729 C for 3 min. The nested PCR conditions were as follows: 949 C for 3 min, followed by 30 cycles of 989 C for 20 s, 599 C for 30 s (E1-A) or 669 C for 30 s (E1-B), 729 C for 1 min, and 729 C for 3 min. The 4 sets of the E1-region-specific primers used are presented in Table 1 . The detection limit of the nested RT-PCR, E1-A and E1-B, was determined to be 100 RNA copies/reaction using synthetic RUBV RNA. Thereafter, the nested PCR products, purified with the Wizard SV Gel and PCR Clean-UP System (Promega, Madison, WI, USA), were sequenced using Big Dye fluorescent dye terminators (Life Technologies). The reaction products were analyzed with an ABI 3130 Genetic Analyzer (Life Technologies). Sequence data were aligned with ClustalW version 2.1. Phylogenetic trees were constructed using neighbor-joining method. The obtained nucleotide sequences were compared with the WHO-recommended reference virus sequences (12) . The MeV genotype was determined based on the nucleotide sequence of the N gene as described previously (6) .
Characteristics of 15 RUBV-and 3 MeV-positive cases determined by the modified RT-PCR are shown in Table 2 . All of these 18 cases were clinically diagnosed with measles. Thus, the RT-PCR protocol presented here could be an effective tool for the laboratory diagnosis of rubella and measles. The results reinforced that virological tests are almost indispensable to maintain the precision of diagnosis of measles/rubella. The other viruses identified in the specimens of RUBV-and MeVnegative cases were as follows (n denotes the number of cases that were positive for each virus for at least 1 specimen): B19V (n ＝ 2), echovirus-3 (n ＝ 1), adenovirus-4 (n ＝ 1). All of these viruses are known to cause fever and rash. These results further implied the contribution of other pathogens to clinically diagnosed measles.
The E1 regions were amplified from 20 (67z) of the 30 specimens, which were positive for the RUBV NS gene. The sequence analysis of the E1 region revealed that the 739-nucleotide sequences of the E1 gene obtained from RUBV-positive patients were characterized as genotype 1E (n ＝ 1) and 2B (n ＝ 12) ( Table 2 ). The epidemiological data showed that 2 cases (Case nos. 12 and 13 in Table 2 ) had a known history of exposure to a patient clinically diagnosed with rubella. In 1 case (Case no. 7), a rubella outbreak at workplace was noted. The other RUBV-positive patients suffered from rubella sporadically, without obvious link to any outbreaks and import cases. The MeV genotypes detected in 2 of the 3 patients were determined as H1 and the other as D9 ( Table 2 ). All of the 3 patients who were positive for MeV had no vaccination history, and 2 of them had returned from China: 1 (Case no. 14 in Table 2 ) had returned on February 21 (1 day before the disease onset) and the other (Case no. 16) had traveled from January 27 to February 23 (5 days before the disease onset). The MeV genotype of the 2 patients who returned from China was H1, which was prevalent in China. The other patient exhibited D9-genotype MeV (Case no. 18), who was reported to have had an intimate exposure to a patient infected with D9-genotype MeV identified by Mie Prefecture Health and Environment Research Institute. Thus, the epidemiological linkage of each measles case, i.e., 2 imported measles and 1 endemic transmission with recently imported MeV strain, was confirmed by a series of laboratory tests, RT-PCR, followed by genotyping. These results indicated that careful surveillance of RUBV and MeV circulation and transmission pathways using laboratory-based techniques for genotyping is important for rubella control and measles elimination.
Recently, the Technical Advisory Group on Immunization and Vaccination of the WHO approved a target of decreasing rubella incidence to º10 cases per million population and CRS incidence to º 10 cases per million live birth by 2015 for the Western Pacific Region (WPR), including Japan (13) . As of May 2013, 42.5 rubella cases per million population were reported in 3) : T, throat swab; U, urine; P, peripheral blood mononuclear cell; B, whole blood; S, serum. 4) : MeV, measles virus; RUBV, rubella virus.
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Detection and Genotyping of Rubella Viruses Japan, which is much higher than the WPR annual incidence target (2) . To prevent RUBV transmission, it is necessary to maintain high levels of vaccination coverage through routine immunization and specifically elevate seropositivity among adult men, because 70z of the reported rubella patients have been noted to be men aged 20-60 years (2) . Simultaneously, virological diagnostic tests performed by national and local public health laboratories are essential to ensure the precision of rubella/measles surveillance and support epidemiological linkage studies. The modified method described here could be useful for this purpose.
